Peng D.

Peng D. is a seasoned medical professional with substantial experience in pathology and medical affairs. Currently serving as a Medical Director at Labcorp since 2021, Peng D. provides consultative and laboratory support while overseeing medical decision-making. Previously, Peng D. held positions as a pathology specialist at Agilent Technologies, where expertise in IHC and FISH scoring was developed, and as a postdoctoral scientist at Cedars-Sinai, focusing on biomarker expression analysis. Additional experience includes serving as a Senior Pathologist at Shanghai East Hospital, where proficiency in pathological diagnoses was gained, and as a Pathologist at Shanghai Pulmonary Hospital, specializing in lung tumors. Peng D. earned an MD and MS in Clinical Medicine with a focus on tumor pathology and pathophysiology from Norman Bethune Medical College at Jilin University.